These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15526807)

  • 1. Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly.
    Lehmann S; Vollset SE; Nygaard HA; Gulsvik A
    Respir Med; 2004 Nov; 98(11):1071-9. PubMed ID: 15526807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonist.
    Lehmann S; Bakke PS; Eide GE; Humerfelt S; Gulsvik A
    Pulm Pharmacol Ther; 2006; 19(4):272-80. PubMed ID: 16169762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical data discriminating between adults with positive and negative results on bronchodilator testing.
    Lehmann S; Bakke PS; Eide GE; Gulsvik A
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):205-13. PubMed ID: 18230255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
    Lehmann S; Bakke PS; Eide GE; Gulsvik A
    Respir Med; 2007 Jun; 101(6):1183-90. PubMed ID: 17188486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Defined on the Basis of Bronchodilator Response and Degree of Emphysema.
    Cosentino J; Zhao H; Hardin M; Hersh CP; Crapo J; Kim V; Criner GJ;
    Ann Am Thorac Soc; 2016 Sep; 13(9):1483-9. PubMed ID: 27268723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Salbutamol in Mixed Obstructive and Restrictive Pattern Spirometry.
    Tuladhar LR; Tamrakar Tuladhar ET
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):279-283. PubMed ID: 30580341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population.
    Jonassen TM; Eagan TM; Bjorvatn B; Lehmann S
    Clin Respir J; 2018 Jan; 12(1):31-39. PubMed ID: 26948980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
    Sposato B; Mariotta S; Ricci A
    J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the bronchodilator test an useful tool to measure asthma control?
    Ferrer Galván M; Javier Alvarez Gutiérrez F; Romero Falcón A; Romero Romero B; Sáez A; Medina Gallardo JF
    Respir Med; 2017 May; 126():26-31. PubMed ID: 28427546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of patients with chronic obstructive pulmonary disease in the primary care setting: focus on the role of spirometry and bronchodilator reversibility.
    Stoloff SW
    J Fam Pract; 2011 Apr; 60(4 Suppl Diagnosis):S9-16. PubMed ID: 21472146
    [No Abstract]   [Full Text] [Related]  

  • 19. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.